Top compounds associated with response to OR2L13


Feature Type Standardized
Nominal ANOVA
mRNA pac-1 CTRPv2 pan-cancer AAC -0.015 0.7
mRNA TPCA-1 GDSC1000 pan-cancer AAC 0.012 0.7
mRNA FR-180204 GDSC1000 pan-cancer AAC -0.014 0.7
mRNA foretinib GDSC1000 pan-cancer AAC -0.013 0.7
mRNA A-804598 CTRPv2 pan-cancer AAC 0.019 0.7
mRNA BRD-K17060750 CTRPv2 pan-cancer AAC 0.015 0.7
mRNA AT13387 CTRPv2 pan-cancer AAC 0.019 0.7
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.013 0.7
mRNA BRD-K42260513 CTRPv2 pan-cancer AAC -0.022 0.7
mRNA Cytarabine GDSC1000 pan-cancer AAC -0.014 0.7
Download CSV